11-028 report ocr 1 |
Previous | 1 of 147 | Next |
|
small (250x250 max)
medium (500x500 max)
large ( > 500x500)
Full Resolution
All (PDF)
|
This page
All
Subset
|
INTERIM STUDY REPORT
Public Safety Committee
Sue Tibbs, Chair
Oklahoma House of Representatives
Interim Study 11-028, Rep. Sue Tibbs and Rep. Ben Sherrer
October 3, 2011
Study of making pseudoephedrine a Class III drug and needing a prescription to obtain
Darrell Weaver
Oklahoma Bureau of Narcotics and Dangerous Drugs Control
Drug enforcement is a different type of law enforcement. It is an in-progress crime. Laws must
be able to adapt and change.
Meth Labs:
2007= 147
2008= 248
2009= 743
2010= 818
In 2004, meth labs cost $1 billion in collateral damage. In 2006, Oregon made pseudoephedrine
products a Schedule III or prescription only drug. After enactment, Oregon saw the largest
decrease in crime rate in the nation. Meth related hospitalizations went down 35% and meth
arrests were reduced 33%. Mississippi enacted similar legislation last year. Meth related
incidents dropped 35%, arrests dropped 62% and there was a 76% reduction in the number of
children removed from meth houses.
The Bureau of Narcotics has been tracking pseudo sales since 2006. OBNDD has the most
efficient tracking system in the nation. In 2010, 1.5 million purchases of pseudoephedrine
products with 93 thousand blocked sales. The industry does not want to see pseudoephedrine
regulation because it is big business and large profits. The NPlex system is run by CHIPPA
with Missouri, Kansas and Texas using the system. NPlex is in a limited number of
pharmacies.
If pseudoephedrine were regulated, the consumer would not have to get a prescription every time
they had a cold.
Regulation would only impact 17 products which contain tablet pseudoephedrine.
David Starkey
StopMethLabs.com
Doesn’t understand why the law hasn’t been changed to regulate pseudoephedrine. Believes the
solution to the meth epidemic is to require prescriptions. Promotes legislation for a statewide
prescription law.
Object Description
Description
| Title | 11-028 report ocr 1 |
| Full text | INTERIM STUDY REPORT Public Safety Committee Sue Tibbs, Chair Oklahoma House of Representatives Interim Study 11-028, Rep. Sue Tibbs and Rep. Ben Sherrer October 3, 2011 Study of making pseudoephedrine a Class III drug and needing a prescription to obtain Darrell Weaver Oklahoma Bureau of Narcotics and Dangerous Drugs Control Drug enforcement is a different type of law enforcement. It is an in-progress crime. Laws must be able to adapt and change. Meth Labs: 2007= 147 2008= 248 2009= 743 2010= 818 In 2004, meth labs cost $1 billion in collateral damage. In 2006, Oregon made pseudoephedrine products a Schedule III or prescription only drug. After enactment, Oregon saw the largest decrease in crime rate in the nation. Meth related hospitalizations went down 35% and meth arrests were reduced 33%. Mississippi enacted similar legislation last year. Meth related incidents dropped 35%, arrests dropped 62% and there was a 76% reduction in the number of children removed from meth houses. The Bureau of Narcotics has been tracking pseudo sales since 2006. OBNDD has the most efficient tracking system in the nation. In 2010, 1.5 million purchases of pseudoephedrine products with 93 thousand blocked sales. The industry does not want to see pseudoephedrine regulation because it is big business and large profits. The NPlex system is run by CHIPPA with Missouri, Kansas and Texas using the system. NPlex is in a limited number of pharmacies. If pseudoephedrine were regulated, the consumer would not have to get a prescription every time they had a cold. Regulation would only impact 17 products which contain tablet pseudoephedrine. David Starkey StopMethLabs.com Doesn’t understand why the law hasn’t been changed to regulate pseudoephedrine. Believes the solution to the meth epidemic is to require prescriptions. Promotes legislation for a statewide prescription law. |
| Date created | 2012-03-06 |
| Date modified | 2012-03-06 |
